Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Elutia Inc. , a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications.

52W Range

20thpctl

Volume

1.44×avg

Market Cap

38.90MUSD

P/E Ratio

0.7TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Elutia Inc

ELUTNASDAQ Capital Market·USD·Closed

Elutia Inc

ELUTNASDAQ·USD·Closed

$0.88

+0.00%

$0.88

+$0.00 (0.00%)

52W Range

20thpctl

Volume

1.44×avg

Mkt Cap

38.90MUSD

P/E

0.7TTM

Div Yield

–ann

ELUT: Elutia Inc Stock Analysis | finqOS